| Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial HM Prince, YH Kim, SM Horwitz, R Dummer, J Scarisbrick, P Quaglino, ... The Lancet 390 (10094), 555-566, 2017 | 558 | 2017 |
| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 524 | 2018 |
| First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open … P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, ... The Lancet 389 (10083), 2031-2040, 2017 | 502 | 2017 |
| Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766, 2015 | 422 | 2015 |
| Blastic NK-Cell Lymphomas (Agranular CD4+ CD56+ Hematodermic Neoplasms) A Review T Petrella, M Bagot, R Willemze, M Beylot-Barry, B Vergier, M Delaunay, ... American journal of clinical pathology 123 (5), 662-675, 2005 | 367 | 2005 |
| Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis AP Villani, M Rouzaud, M Sevrain, T Barnetche, C Paul, MA Richard, ... Journal of the American Academy of Dermatology 73 (2), 242-248, 2015 | 339 | 2015 |
| Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases B Vergier, A de Muret, M Beylot-Barry, L Vaillant, D Ekouevi, G Chene, ... Blood, The Journal of the American Society of Hematology 95 (7), 2212-2218, 2000 | 339 | 2000 |
| Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases F Grange, M Beylot-Barry, P Courville, E Maubec, M Bagot, B Vergier, ... Archives of dermatology 143 (9), 1144-1150, 2007 | 317 | 2007 |
| Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective … M Kostine, L Rouxel, T Barnetche, R Veillon, F Martin, C Dutriaux, ... Annals of the rheumatic diseases 77 (3), 393-398, 2018 | 271 | 2018 |
| Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus P Joly, C Richard, D Gilbert, P Courville, O Chosidow, JC Roujeau, ... Journal of the American Academy of Dermatology 43 (4), 619-626, 2000 | 255 | 2000 |
| Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: a nationwide, multicenter cohort study A Tison, G Quéré, L Misery, E Funck‐Brentano, FX Danlos, E Routier, ... Arthritis & rheumatology 71 (12), 2100-2111, 2019 | 239 | 2019 |
| A Phase II trial of Belinostat (PXD 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma F Foss, R Advani, M Duvic, KB Hymes, T Intragumtornchai, A Lekhakula, ... British journal of haematology 168 (6), 811-819, 2015 | 205 | 2015 |
| Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients F Julia, T Petrella, M Beylot‐Barry, M Bagot, D Lipsker, L Machet, P Joly, ... British Journal of Dermatology 169 (3), 579-586, 2013 | 200 | 2013 |
| Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study T Jouary, C Leyral, B Dreno, A Doussau, B Sassolas, M Beylot-Barry, ... Annals of Oncology 23 (4), 1074-1080, 2012 | 197 | 2012 |
| Delays in diagnosis and melanoma prognosis (I): the role of patients MA Richard, JJ Grob, MF Avril, M Delaunay, J Gouvernet, P Wolkenstein, ... International journal of cancer 89 (3), 271-279, 2000 | 191 | 2000 |
| Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? S Dalle, M Beylot‐Barry, M Bagot, D Lipsker, L Machet, P Joly, ... British Journal of Dermatology 162 (1), 74-79, 2010 | 187 | 2010 |
| The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, ... British Journal of Dermatology 181 (2), 350-357, 2019 | 174 | 2019 |
| Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome F Grange, G Hedelin, P Joly, M Beylot-Barry, M D’Incan, M Delaunay, ... Blood, The Journal of the American Society of Hematology 93 (11), 3637-3642, 1999 | 163 | 1999 |
| Melanoma and tumor thickness: challenges of early diagnosis MA Richard, JJ Grob, MF Avril, M Delaunay, X Thirion, P Wolkenstein, ... Archives of dermatology 135 (3), 269-274, 1999 | 163 | 1999 |
| Acute generalized exanthematous pustulosis. C Beylot, MS Doutre, M Beylot-Barry Seminars in cutaneous medicine and surgery 15 (4), 244-249, 1996 | 155 | 1996 |
